The Eli Lilly And Co (NYSE: LLY) plant being readied to make an antibody therapy for COVID-19 has been found to have serious quality control problems by the United States Food and Drug Administration, Reuters reported Tuesday. What Happened: As per government documents, two inspectors who visited the drugmaker’s B
Full Story >>
Vote
+12